QuidelOrtho Launches Certified Analyzer Program to Expand Diagnostic Testing in Underserved Communities

QuidelOrtho has launched a Certified Analyzer Program to expand access to high-quality diagnostic testing in underserved U.S. communities. The program offers certified VITROS analyzers with proven reliability and quality results, award-winning service, and a fraction of the cost. The analyzers undergo a rigorous certification process and include a 12-month warranty on service and support. The program aims to improve accessibility and access to diagnostic solutions for healthcare providers in underserved communities.

QuidelOrtho Corporation has launched the Certified Analyzer Program, an initiative aimed at enhancing access to high-quality diagnostic testing in underserved U.S. communities. The program targets healthcare facilities with fewer than 100 beds, including rural hospitals, community clinics, and small physician office labs. By offering certified VITROS™ analyzers at a reduced cost, QuidelOrtho aims to improve diagnostic capabilities and patient outcomes in these underserved areas.

The Certified Analyzer Program features certified VITROS XT 7600 and 5600 Integrated Systems, as well as the VITROS 3600 Immunodiagnostic System. Each analyzer undergoes a rigorous certification process at QuidelOrtho's Rochester facility, involving over 140 system checks, hardware maintenance, and extensive performance testing. The certified analyzers come with a 12-month warranty on service and support, ensuring reliability and quality.

According to Audra Jones, Senior Vice President, North America, QuidelOrtho, the program is designed to equip healthcare facilities with reliable diagnostic technology while providing award-winning service and customer satisfaction. By expanding access to diagnostic solutions, QuidelOrtho seeks to empower healthcare providers in underserved communities to deliver diagnostic excellence to their patients.

The launch of the Certified Analyzer Program aligns with QuidelOrtho's mission to advance diagnostics and improve patient outcomes. The company's focus on innovation and quality has positioned it as a leader in the in vitro diagnostics industry, with a strong track record of delivering accurate and reliable diagnostic solutions.

[1] https://www.prnewswire.com/news-releases/quidelortho-launches-certified-analyzer-program-302529278.html
[2] https://finance.yahoo.com/news/why-quidelortho-qdel-top-growth-134503196.html
[3] https://www.stocktitan.net/news/QDEL/quidel-ortho-launches-certified-analyzer-06dxmbzxoamp.html